Managers / Q4 2024 · view latest →
Intrinsic Value Partners, LLC
CIK 0001910364 · 4742 N. 24TH STREET, SUITE 300, PHOENIX, AZ, 85016 · 480-522-2032
Summary
Intrinsic Value Partners, LLC reported $100M in U.S.-listed holdings across 59 positions for Q4 2024.
Its largest position, BRK/B, represents 14.7% of the portfolio.
Compared with Q3 2024, the fund opened 0 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 88.5% · $88M
- ETP · 5.8% · $6M
- ADR · 5.0% · $5M
- Other · 0.7% · $724,962
Quarter-over-Quarter Changes full breakdown →
vs Q3 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| VTVVanguard Value Etf | ADDED | +6.9K | 10.1K | +$1M | $2M |
| ENOVEnovis Corp | SOLD OUT | −5.0K | 0 | −$216,025 | $0 |
| JNJJohnson & Johnson | SOLD OUT | −1.3K | 0 | −$206,226 | $0 |
| KVUEKenvue Inc | SOLD OUT | −8.8K | 0 | −$202,827 | $0 |
| MRNAModerna | TRIMMED | −15.1K | 36.3K | −$2M | $2M |
| BABAAlibaba Group Hldg Ltd ADR | TRIMMED | −1.3K | 4.0K | −$225,359 | $341,110 |
| GEVGe Vernova Inc | TRIMMED | −592 | 2.0K | −$3,713 | $654,900 |
| OXYOccidental Pete Corp | ADDED | +6.7K | 45.0K | +$248,083 | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $130M | 69 | Apr 28, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $133M | 69 | Jan 21, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $123M | 67 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $112M | 67 | Jul 21, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $101M | 66 | May 8, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $100M | 59 | Jan 30, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $100M | 62 | Nov 4, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $96M | 59 | Jul 25, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $94M | 56 | Apr 22, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $86M | 53 | Feb 7, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $78M | 52 | Oct 17, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $79M | 54 | Aug 2, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | Under review | 54 | Apr 18, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | Under review | 53 | Jan 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $72M | 53 | Oct 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $78M | 53 | Jul 18, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $94M | 48 | Apr 28, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $94M | 47 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.